AIMM Therapeutics

    OverviewSuggest Edit

    AIMM Therapeutics is a company engaged in the development of therapeutic and prophylactic human monoclonal antibodies. Its current pipeline includes antibodies against the respiratory syncytial virus, influenza virus and staphylococcus aureus, melanoma, and some cancer types.
    TypePrivate
    Founded2004
    Websiteaimmtherapeutics.com

    Latest Updates

    Employees (est.) (Mar 2020)30

    AIMM Therapeutics Financials and Metrics

    Summary Metrics

    Founding Date

    2004
    Show all financial metrics

    AIMM Therapeutics Online and Social Media Presence

    Embed Graph

    AIMM Therapeutics Frequently Asked Questions

    • When was AIMM Therapeutics founded?

      AIMM Therapeutics was founded in 2004.

    • How many employees does AIMM Therapeutics have?

      AIMM Therapeutics has 30 employees.

    • Who are AIMM Therapeutics competitors?

      Competitors of AIMM Therapeutics include OSE Immunotherapeutics, G1 Therapeutics and PDL BioPharma.